124 related articles for article (PubMed ID: 35854457)
21. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling.
Lu CC; Yang JS; Chiang JH; Hour MJ; Amagaya S; Lu KW; Lin JP; Tang NY; Lee TH; Chung JG
Anticancer Res; 2012 Jul; 32(7):2895-903. PubMed ID: 22753753
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
[TBL] [Abstract][Full Text] [Related]
25. 4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
Yu FS; Lin ML; Hsu SC; Yu CC; Huang YP; Kuo YH; Chung JG
Int J Oncol; 2016 Aug; 49(2):579-88. PubMed ID: 27221634
[TBL] [Abstract][Full Text] [Related]
26. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.
Wu YJ; Neoh CA; Tsao CY; Su JH; Li HH
Int J Mol Sci; 2015 Jul; 16(7):16469-82. PubMed ID: 26204832
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
28. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
29. Coronarin D suppresses proliferation, invasion and migration of glioma cells via activating JNK signaling pathway.
Zhou H; Liu J; Chen Z
Pathol Res Pract; 2020 Feb; 216(2):152789. PubMed ID: 31870592
[TBL] [Abstract][Full Text] [Related]
30. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
31. Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
Hsieh MH; Tsai JP; Yang SF; Chiou HL; Lin CL; Hsieh YH; Chang HR
Cells; 2019 Aug; 8(9):. PubMed ID: 31438640
[TBL] [Abstract][Full Text] [Related]
32. Salvianolic acid A suppresses MMP-2 expression and restrains cancer cell invasion through ERK signaling in human nasopharyngeal carcinoma.
Chuang CY; Ho YC; Lin CW; Yang WE; Yu YL; Tsai MC; Yang SF; Su SC
J Ethnopharmacol; 2020 Apr; 252():112601. PubMed ID: 31981746
[TBL] [Abstract][Full Text] [Related]
33. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
Chen PS; Shih YW; Huang HC; Cheng HW
PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
[TBL] [Abstract][Full Text] [Related]
34. Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway.
Sun Y; Lan M; Chen X; Dai Y; Zhao X; Wang L; Zhao T; Li Y; Zhu J; Zhang X; Jiang H; Wu X; Chen C; Zhang T; Yan Z
Biomed Pharmacother; 2018 Aug; 104():817-824. PubMed ID: 29703569
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells.
Gweon EJ; Kim SJ
Oncol Rep; 2013 Feb; 29(2):826-34. PubMed ID: 23229870
[TBL] [Abstract][Full Text] [Related]
36. Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells.
Park SY; Chae SY; Park JO; Lee KJ; Park G
Oncol Rep; 2016 Jun; 35(6):3248-56. PubMed ID: 27035791
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expression.
Lee SJ; Cho SC; Lee EJ; Kim S; Lee SB; Lim JH; Choi YH; Kim WJ; Moon SK
J Biol Chem; 2013 Feb; 288(8):5539-52. PubMed ID: 23271730
[TBL] [Abstract][Full Text] [Related]
38. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the invasion and migration of renal carcinoma 786‑o‑si3 cells in vitro and in vivo by Koelreuteria formosana extract.
Lin CY; Chen PN; Hsu LS; Kuo DY; Chu SC; Hsieh YS
Mol Med Rep; 2014 Dec; 10(6):3334-42. PubMed ID: 25241754
[TBL] [Abstract][Full Text] [Related]
40. Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer.
Fu Z; Lin L; Liu S; Qin M; He S; Zhu L; Huang J
Med Sci Monit; 2019 Sep; 25():6836-6845. PubMed ID: 31509521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
